The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate ...

NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...

A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

Retinal degeneration leads to irreversible vision loss and significantly impacts quality of life. Approximately 19.83 million Americans over the age of 40 are affected by age-related macular ...

Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox ...

“How old would you like to be when you die?” That’s the question my primary care physician asked during my routine physical. It’s a complex question, one without a right answer. As long as possible, ...